March 18, 2011 (Vienna, Austria) — L-methylfolate is showing promise as an augmenting agent for depressed patients who are unresponsive to traditional antidepressants, new research suggested.
LAS VEGAS--(BUSINESS WIRE)--Data presented today at the 24 th annual U.S. Psychiatric and Mental Health Congress add to the body of evidence suggesting that Deplin ® (L-methylfolate 15 mg) is an ...
COVINGTON, La.--(BUSINESS WIRE)--An evaluation of the benefits of adjunctive L-methylfolate in patients stratified by specific biomarkers and genotypes who were poorly responding to selective ...
Depressed individuals with low serum folate and B12 levels and elevated serum homocysteine levels often fail to respond to conventional antidepressants. Elevated serum homocysteine is a marker for ...
SAN FRANCISCO — Metabolic biomarkers may help identify differences in response to adjunctive L-methylfolate in patients with major depressive disorder (MDD), new research analysis suggests. In the ...
Details concerning the L-Methylfolate 7.5mg medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback